Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › San Bernardino › NPI 1235290818
Hospital

Community Hospital of San Bernardino

Community Hospital of San Bernardino was paid $114.16M by Medicaid between Jan 2018 and Dec 2024, across 264 billing codes. Its largest line is 0450, Emergency room services — 54% of everything it billed.

33Billing provider infoCOMMUNITY HOSPITAL OF SAN BERNARDINO
SAN BERNARDINO, CA 92411
33aNPI1235290818assigned 12/13/2006
33bProvider typePsychiatric Hospital Unit
28Total paid$114.16M
24GClaims1,601,064
24DCodes billed264
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Psychiatric Hospital Unit providers in California

Rank by total paid#2 of 33
Median peer was paid$361K
This provider vs. median316×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018264,746$16.43M
2019292,449$19.40M
2020194,768$14.51M
2021206,096$16.23M
2022236,523$19.53M
2023266,602$20.23M
2024incomplete139,880$7.82M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 54% 153,775 131,636 $61.48M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 32% 74,353 66,348 $36.37M
Z7502 1.3% 40,681 39,554 $1.53M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 17,620 16,229 $914K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 9,234 8,873 $798K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity <1% 7,240 6,676 $790K
0360 <1% 5,394 2,916 $765K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 4,657 4,602 $582K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 1,734 1,720 $575K
99499 <1% 8,233 6,834 $458K
G0378 Hospital observation service, per hour <1% 3,469 2,519 $417K
0762 <1% 4,844 3,463 $402K
252 more codes
99221 <1% 1,894 $363K
99285 Emergency room visit (most serious) <1% 3,680 $359K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 5,652 $349K
80053 Comprehensive metabolic panel <1% 85,473 $341K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 3,608 $293K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 24,933 $279K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,535 $277K
J3490 Unclassified drugs <1% 77,151 $273K
70450 Computed tomography, head or brain; without contrast material <1% 10,419 $272K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 34,546 $271K
0720 <1% 6,905 $270K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 7,087 $240K
99070 <1% 89,526 $227K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 89,903 $209K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 31,217 $205K
V5008 Hearing screening <1% 3,555 $188K
97802 <1% 1,573 $175K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 1,798 $166K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 7,962 $150K
96375 Therapeutic injection; each additional sequential IV push <1% 20,666 $143K
47562 <1% 451 $136K
59025 Fetal non-stress test <1% 5,765 $129K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 8,743 $123K
71045 Radiologic examination, chest; single view <1% 30,741 $122K
90853 Group psychotherapy (other than of a multiple-family group) <1% 4,067 $122K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,705 $119K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 1,445 $112K
0710 <1% 3,115 $109K
76801 <1% 5,858 $100K
92588 <1% 1,658 $91K
76819 Fetal biophysical profile; without non-stress testing <1% 1,202 $88K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,812 $88K
87086 Culture, bacterial; quantitative colony count, urine <1% 26,318 $86K
71046 Radiologic examination, chest; 2 views <1% 18,982 $81K
Z9725 <1% 1,854 $78K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 6,417 $76K
Z7610 <1% 14,083 $75K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,570 $74K
96361 Intravenous infusion, hydration; each additional hour <1% 7,384 $72K
J7030 Infusion, normal saline solution , 1000 cc <1% 36,474 $67K
99218 <1% 366 $67K
81001 <1% 54,524 $65K
99238 Hospital discharge day management, 30 minutes or less <1% 1,829 $65K
97803 <1% 911 $65K
72125 Computed tomography, cervical spine; without contrast material <1% 2,051 $63K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 11,427 $58K
81025 <1% 35,431 $56K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 4,053 $49K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 796 $48K
36415 Collection of venous blood by venipuncture <1% 15,672 $45K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,883 $40K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,802 $39K
85730 <1% 8,754 $39K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 3,807 $39K
84484 <1% 20,693 $37K
84703 <1% 8,832 $37K
83690 <1% 28,702 $36K
99232 Hospital visit by a doctor, follow-up day <1% 434 $35K
71275 Computed tomographic angiography, chest, with contrast material <1% 943 $34K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 972 $33K
93971 <1% 1,976 $31K
70486 <1% 1,243 $29K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 191 $27K
85610 <1% 9,924 $26K
82962 <1% 23,190 $25K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 28,985 $25K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 69 $24K
88304 <1% 1,966 $24K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 591 $23K
93976 <1% 1,003 $22K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 9,252 $22K
84702 <1% 8,136 $22K
L8699 Prosthetic implant, not otherwise specified <1% 40 $22K
83880 <1% 4,916 $22K
80048 Basic metabolic panel (calcium, ionized) <1% 6,680 $21K
0250 <1% 4,033 $21K
85027 <1% 5,750 $19K
76830 Ultrasound, transvaginal <1% 1,332 $19K
0949 <1% 276 $18K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 26,129 $17K
87040 <1% 5,570 $16K
99224 <1% 210 $16K
J2270 Injection, morphine sulfate, up to 10 mg <1% 14,548 $15K
73610 <1% 3,451 $15K
72131 <1% 273 $14K
93975 <1% 502 $14K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 6,855 $13K
73562 <1% 3,751 $13K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 12,852 $13K
73030 <1% 2,418 $12K
73630 <1% 3,686 $12K
73130 <1% 3,432 $12K
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 1,346 $12K
99217 <1% 345 $12K
J2704 Injection, propofol, 10 mg <1% 4,919 $11K
87077 <1% 5,466 $11K
74018 <1% 2,940 $11K
83605 <1% 6,393 $11K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 10,524 $11K
97804 <1% 226 $11K
87186 <1% 4,939 $10K
81003 <1% 16,309 $10K
82248 <1% 2,685 $10K
J1815 Injection, insulin, per 5 units <1% 1,725 $10K
93970 <1% 287 $10K
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,354 $10K
90715 <1% 2,610 $9K
73110 <1% 2,237 $9K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 69 $9K
C1889 Implantable/insertable device, not otherwise classified <1% 46 $9K
84443 Thyroid stimulating hormone (TSH) <1% 3,089 $9K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 877 $9K
72100 <1% 1,930 $9K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 652 $8K
86850 <1% 2,639 $8K
C1781 Mesh (implantable) <1% 13 $8K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,549 $8K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 493 $7K
71020 <1% 463 $7K
A9270 Non-covered item or service <1% 4,950 $7K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 70 $7K
73080 <1% 1,522 $7K
12001 <1% 1,706 $7K
J0690 Injection, cefazolin sodium, 500 mg <1% 3,050 $7K
Z7500 <1% 192 $7K
88342 <1% 302 $7K
29125 <1% 1,487 $6K
36821 <1% 25 $6K
87210 <1% 2,331 $6K
88341 <1% 28 $6K
0270 <1% 1,346 $6K
72040 <1% 954 $6K
10060 <1% 1,330 $6K
86900 <1% 2,728 $6K
82550 <1% 4,770 $6K
Q3014 Telehealth originating site facility fee <1% 1,337 $6K
84145 <1% 1,758 $5K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 79 $5K
82247 <1% 2,850 $5K
86901 <1% 4,925 $5K
83735 <1% 4,756 $5K
12011 <1% 1,163 $5K
87147 <1% 996 $5K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 343 $4K
29515 <1% 1,352 $4K
87581 <1% 2,108 $4K
87486 <1% 2,108 $4K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 2,127 $4K
85379 <1% 2,589 $3K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 177 $3K
S0077 Injection, clindamycin phosphate, 300 mg <1% 809 $3K
96367 <1% 436 $3K
0750 <1% 28 $3K
82731 <1% 47 $3K
85384 <1% 284 $3K
82803 <1% 593 $3K
73140 <1% 940 $3K
88307 <1% 64 $3K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 724 $3K
83036 Hemoglobin; glycosylated (A1C) <1% 473 $2K
73590 <1% 686 $2K
94729 <1% 50 $2K
87400 <1% 633 $2K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 4,811 $2K
83615 <1% 355 $2K
74019 <1% 546 $2K
73090 <1% 676 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 5,432 $2K
88302 <1% 154 $2K
70491 <1% 59 $2K
73502 <1% 502 $2K
94060 <1% 55 $2K
76870 <1% 346 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,490 $2K
72128 <1% 25 $2K
94727 <1% 38 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,076 $1K
74021 <1% 373 $1K
J7050 Infusion, normal saline solution, 250 cc <1% 2,065 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,981 $1K
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 219 $1K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 14 $1K
30520 <1% 12 $1K
86780 <1% 177 $1K
J1335 Injection, ertapenem sodium, 500 mg <1% 26 $1K
71101 <1% 318 $1K
12002 <1% 358 $1K
74022 <1% 385 $983.20
29530 <1% 244 $982.89
J1596 Injection, glycopyrrolate, 0.1 mg <1% 358 $972.45
82570 <1% 147 $802.78
J2060 Injection, lorazepam, 2 mg <1% 2,099 $781.49
J1644 Injection, heparin sodium, per 1000 units <1% 415 $770.44
J3105 Injection, terbutaline sulfate, up to 1 mg <1% 207 $731.75
71010 <1% 94 $685.21
10061 <1% 190 $678.02
71250 <1% 13 $677.08
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,736 $651.94
85007 <1% 1,943 $637.76
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 72 $589.51
82553 <1% 623 $582.59
J0360 Injection, hydralazine hcl, up to 20 mg <1% 371 $576.73
J3475 Injection, magnesium sulfate, per 500 mg <1% 627 $536.14
86141 <1% 391 $518.99
96376 <1% 1,113 $468.53
84439 <1% 408 $437.69
J2440 Injection, papaverine hcl, up to 60 mg <1% 16 $433.18
87081 <1% 261 $416.77
74000 <1% 33 $406.80
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 12 $399.09
84156 <1% 104 $374.35
99001 <1% 60 $368.00
84550 <1% 216 $346.55
0370 <1% 12 $329.70
87070 <1% 92 $326.29
0001A <1% 19 $321.86
J1953 Injection, levetiracetam, 10 mg <1% 42 $292.48
99153 Mod sedat endo service >5yrs <1% 20 $282.52
82140 <1% 179 $268.22
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 42 $253.00
80061 Lipid panel <1% 258 $219.56
0272 <1% 12 $218.49
88313 <1% 13 $200.50
J3370 Injection, vancomycin hcl, 500 mg <1% 51 $192.88
J1171 Injection, hydromorphone, 0.1 mg <1% 42 $158.40
87205 <1% 148 $146.44
99152 <1% 14 $145.54
84100 <1% 408 $139.28
72072 <1% 43 $137.75
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 13 $113.15
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 13 $88.00
S0164 Injection, pantoprazole sodium, 40 mg <1% 136 $77.56
J2720 Injection, protamine sulfate, per 10 mg <1% 26 $75.85
85380 <1% 65 $68.60
85652 <1% 183 $55.25
73552 <1% 13 $48.70
J2550 Injection, promethazine hcl, up to 50 mg <1% 40 $45.51
70360 <1% 25 $37.79
29105 <1% 90 $34.68
J1805 Injection, esmolol hydrochloride, 10 mg <1% 14 $30.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 41 $25.00
J0456 Injection, azithromycin, 500 mg <1% 27 $23.76
J1940 Injection, furosemide, up to 20 mg <1% 44 $21.04
80076 <1% 12 $20.42
73060 <1% 14 $19.38
29130 <1% 28 $18.72
85014 <1% 44 $2.68
85018 <1% 44 $2.59
82009 0% 17 $0.00
Q4051 Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) 0% 80 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 13 $0.00
76377 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVANDENBOSCH, DARRYL (CFO)